{"id":507,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2015-04-30","marketCap":3685.072265625,"name":"Blueprint Medicines Corp","phone":"16173747580.0","outstanding":60.790000915527344,"symbol":"BPMC","website":"https://www.blueprintmedicines.com/","industry":"Biotechnology"},"price":60.02,"year":2023,"month":11,"day":8,"weekday":"Wednesday","title":"The Role of Market Analysts and Their Predictions in Influencing Blueprint Medicines Corp Stock Prices","date":"2023-11-08","url":"/posts/2023/11/08/BPMC","content":[{"section":"Introduction","text":"Market analysts are professionals who analyze financial markets and provide predictions about the future performance of companies, including Blueprint Medicines Corp. Their predictions can have a significant impact on the stock prices of the company."},{"section":"Influence of Analyst Predictions","text":"Analyst predictions can influence investor sentiment and behavior. When analysts provide positive forecasts for Blueprint Medicines Corp, investors may perceive it as a sign of future growth and profitability, leading to increased demand for the company's stock. This increased demand can drive up the stock prices."},{"section":"Assessing Analyst Forecasts","text":"It is essential to critically assess analyst forecasts before making any investment decisions. Analysts may have varying levels of expertise and access to information, which can impact the accuracy of their predictions. Moreover, analysts may have conflicts of interest, such as receiving compensation from investment banks that have a stake in Blueprint Medicines Corp. These conflicts can influence their objectivity and potentially bias their forecasts."},{"section":"Consider Multiple Analysts","text":"To obtain a more comprehensive and balanced perspective, it is advisable to consider forecasts from multiple analysts. By comparing and contrasting predictions from different sources, investors can better evaluate the consensus and identify potential biases or outliers."},{"section":"Limitations of Analyst Predictions","text":"It is crucial to recognize the limitations of analyst predictions. Even the most experienced analysts can be incorrect in their forecasts due to unforeseen events, changes in market conditions, or inaccurate information. Therefore, it is essential not to solely rely on analyst predictions but to consider them as one of many factors when making investment decisions."},{"section":"Market Reaction to Analyst Predictions","text":"In some cases, the stock prices of Blueprint Medicines Corp can experience significant fluctuations based on market reaction to analyst predictions. Positive forecasts may result in a surge in stock prices, while negative forecasts can lead to a decline. However, these price movements may not always align with the long-term fundamentals of the company, and short-term market reactions should be interpreted with caution."},{"section":"Conclusion","text":"Market analysts have a role in influencing Blueprint Medicines Corp stock prices through their predictions. However, it is crucial to critically assess these forecasts, considering the analysts' expertise, potential conflicts of interest, and limitations. Investors should incorporate multiple sources of information and not rely solely on analyst predictions when making investment decisions."}],"tags":["CrossOver55","Long","Biotechnology"],"news":[{"category":"company","date":1699081363,"headline":"Director Jeffrey Albers Sells 10,000 Shares of Blueprint Medicines Corp","id":123625484,"image":"","symbol":"BPMC","publisher":"Yahoo","summary":"On November 3, 2023, Jeffrey Albers, a director at Blueprint Medicines Corp (NASDAQ:BPMC), sold 10,000 shares of the company's stock.","url":"https://finance.yahoo.com/news/director-jeffrey-albers-sells-10-070243755.html"},{"category":"company","date":1699041660,"headline":"Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","id":123595075,"image":"https://media.zenfs.com/en/prnewswire.com/c740bc0c838c53d3519efe12ecb79940","symbol":"BPMC","publisher":"Yahoo","summary":"Blueprint Medicines Corporation (Nasdaq: BPMC), today announced that, effective November 1, 2023, the Compensation Committee of Blueprint Medicines' Board of Directors granted non-qualified stock options to purchase an aggregate of 5,034 shares of its common stock and an aggregate of 2,517 restricted stock units (RSUs) to three new employees under Blueprint Medicines' 2020 Inducement Plan.","url":"https://finance.yahoo.com/news/blueprint-medicines-announces-inducement-grants-200100438.html"},{"category":"company","date":1698886980,"headline":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Blueprint Medicines (BPMC), Bioxcel Therapeutics (BTAI) and Aldeyra Therapeutics (ALDX)","id":123592706,"image":"","symbol":"BPMC","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3190815230"},{"category":"company","date":1698873072,"headline":"Blueprint Medicines (BPMC) Price Target Increased by 5.91% to 80.58","id":123550031,"image":"","symbol":"BPMC","publisher":"Fintel","summary":"","url":"https://fintel.io/news/blueprint-medicines-bpmc-price-target-increased-by-591-to-8058-903"},{"category":"company","date":1698760509,"headline":"How Much Upside is Left in Blueprint Medicines (BPMC)? Wall Street Analysts Think 42.16%","id":123531161,"image":"https://s.yimg.com/ny/api/res/1.2/gZA5XMnsr1RRZw6lGNAcdA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD05NDA-/https://media.zenfs.com/en/zacks.com/c65fb4556b91b6c9dc83e4eff25fede0","symbol":"BPMC","publisher":"Yahoo","summary":"The average of price targets set by Wall Street analysts indicates a potential upside of 42.2% in Blueprint Medicines (BPMC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.","url":"https://finance.yahoo.com/news/much-upside-left-blueprint-medicines-135509556.html"},{"category":"company","date":1698759609,"headline":"Are Medical Stocks Lagging  Biohaven Ltd. (BHVN) This Year?","id":123531162,"image":"https://media.zenfs.com/en/zacks.com/62d8c8e05376a18ba1420a1733ffdda4","symbol":"BPMC","publisher":"Yahoo","summary":"Here is how Biohaven Ltd. (BHVN) and Blueprint Medicines (BPMC) have performed compared to their sector so far this year.","url":"https://finance.yahoo.com/news/medical-stocks-lagging-biohaven-ltd-134009949.html"},{"category":"company","date":1698746699,"headline":"Analysts Just Published A Bright New Outlook For Blueprint Medicines Corporation's (NASDAQ:BPMC)","id":123520309,"image":"https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","symbol":"BPMC","publisher":"Yahoo","summary":"Blueprint Medicines Corporation ( NASDAQ:BPMC ) shareholders will have a reason to smile today, with the analysts...","url":"https://finance.yahoo.com/news/analysts-just-published-bright-outlook-100459425.html"},{"category":"company","date":1698717720,"headline":"Wall Street Analysts Are Bullish on Top Healthcare Picks","id":123527534,"image":"","symbol":"BPMC","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3186596770"},{"category":"company","date":1698715560,"headline":"Skeptical Outlook on Blueprint Medicines Despite Strong Q1 Results: A Sell Rating Maintained","id":123537754,"image":"","symbol":"BPMC","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3186569203"},{"category":"company","date":1698695160,"headline":"Top 20 Genomics Companies in the World","id":123504319,"image":"https://s.yimg.com/ny/api/res/1.2/yPPsV15gQeSt7GxT0DFmsw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/999755402da085bcfaa0a042abb184c2","symbol":"BPMC","publisher":"Yahoo","summary":"In this piece, we will take a look at the top 20 genomics companies in the world. If you want to skip our analysis of the genomics industry, then take a look at the Top 5 Genomics Companies in the World. Modern day science has delivered a plethora of advancements that have enabled humans to […]","url":"https://finance.yahoo.com/news/top-20-genomics-companies-world-194600414.html"},{"category":"company","date":1698570660,"headline":"Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Blueprint Medicines (BPMC)","id":123499426,"image":"","symbol":"BPMC","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3184496012"},{"category":"company","date":1698515359,"headline":"Blueprint Medicines Corporation (NASDAQ:BPMC) Q3 2023 Earnings Call Transcript","id":123482818,"image":"https://media.zenfs.com/en/insidermonkey.com/843261487b0e5ce946ab5ddb0bb1f4df","symbol":"BPMC","publisher":"Yahoo","summary":"Blueprint Medicines Corporation (NASDAQ:BPMC) Q3 2023 Earnings Call Transcript October 26, 2023 Blueprint Medicines Corporation beats earnings expectations. Reported EPS is $-2.2, expectations were $-2.39. Operator: Good morning. My name is Elliot and I will be your conference operator today. At this time, I would like to welcome everyone to the Blueprint Medicines’ Third Quarter […]","url":"https://finance.yahoo.com/news/blueprint-medicines-corporation-nasdaq-bpmc-174919355.html"},{"category":"company","date":1698429681,"headline":"Barclays Maintains Blueprint Medicines (BPMC) Equal-Weight Recommendation","id":123455714,"image":"","symbol":"BPMC","publisher":"Fintel","summary":"","url":"https://fintel.io/news/barclays-maintains-blueprint-medicines-bpmc-equal-weight-recommendation-761"},{"category":"company","date":1698429679,"headline":"Oppenheimer Upgrades Blueprint Medicines (BPMC)","id":123455715,"image":"","symbol":"BPMC","publisher":"Fintel","summary":"","url":"https://fintel.io/news/oppenheimer-upgrades-blueprint-medicines-bpmc-561"},{"category":"company","date":1698429676,"headline":"Morgan Stanley Maintains Blueprint Medicines (BPMC) Equal-Weight Recommendation","id":123455717,"image":"","symbol":"BPMC","publisher":"Fintel","summary":"","url":"https://fintel.io/news/morgan-stanley-maintains-blueprint-medicines-bpmc-equal-weight-recommendation-301"},{"category":"company","date":1698429676,"headline":"Needham Maintains Blueprint Medicines (BPMC) Buy Recommendation","id":123455716,"image":"","symbol":"BPMC","publisher":"Fintel","summary":"","url":"https://fintel.io/news/needham-maintains-blueprint-medicines-bpmc-buy-recommendation-467"},{"category":"company","date":1698415282,"headline":"Roblox upgraded, Bristol Myers downgraded: Wall Street's top analyst calls","id":123450827,"image":"https://media.zenfs.com/en/the_fly_169/135b0749a3ad5e86fe326a9da1d664b6","symbol":"BPMC","publisher":"Yahoo","summary":"Roblox upgraded, Bristol Myers downgraded: Wall Street's top analyst calls","url":"https://finance.yahoo.com/news/roblox-upgraded-bristol-myers-downgraded-140122888.html"},{"category":"company","date":1698406020,"headline":"Blueprint (BPMC) Stock Gains 26% on Q3 Earnings \u0026 Sales Beat","id":123451203,"image":"https://media.zenfs.com/en/zacks.com/4c098652d5bb2f153fa5d3ae51dd3b57","symbol":"BPMC","publisher":"Yahoo","summary":"Blueprint (BPMC) climbs 26% on better-than-expected third-quarter 2023 results, driven by increased Ayvakit sales following the drug's label expansion in the United States.","url":"https://finance.yahoo.com/news/blueprint-bpmc-stock-gains-26-112700339.html"},{"category":"company","date":1698386629,"headline":"Blueprint Medicines' Ayvakit: Capturing The ISM Niche (Rating Upgrade)","id":123448107,"image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1488349703/image_1488349703.jpg?io=getty-c-w1536","symbol":"BPMC","publisher":"SeekingAlpha","summary":"Blueprint Medicines' Q3 2023 earnings showed a 90% YoY increase in product sales driven by Ayvakit, but total revenue dipped. Read more here.","url":"https://seekingalpha.com/article/4644335-blueprint-medicine-q3-earnings-ayvakit-capturing-ism-niche-rating-upgrade"},{"category":"company","date":1698386520,"headline":"Analysts Conflicted on These Healthcare Names: Blueprint Medicines (BPMC), Abbott Labs (ABT) and Merck \u0026 Company (MRK)","id":123454823,"image":"","symbol":"BPMC","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3181120987"},{"category":"company","date":1698384840,"headline":"Blueprint Medicines upgraded to Outperform from Perform at Oppenheimer","id":123462537,"image":"","symbol":"BPMC","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3181094754"},{"category":"company","date":1698384060,"headline":"Analysts Are Bullish on Top Healthcare Stocks: Alnylam Pharma (ALNY), Sanofi (SNYNF)","id":123456317,"image":"","symbol":"BPMC","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3181083003"},{"category":"company","date":1698381240,"headline":"Blueprint Medicines price target raised to $58 from $46 at Barclays","id":123462540,"image":"","symbol":"BPMC","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3181043889"},{"category":"company","date":1698378145,"headline":"Q3 2023 Blueprint Medicines Corp Earnings Call","id":123451204,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"BPMC","publisher":"Yahoo","summary":"Q3 2023 Blueprint Medicines Corp Earnings Call","url":"https://finance.yahoo.com/news/q3-2023-blueprint-medicines-corp-034225061.html"},{"category":"company","date":1698356820,"headline":"Why Blueprint Medicines Stock Soared Today","id":123438164,"image":"https://s.yimg.com/ny/api/res/1.2/k.oNqmat7lfjNMNCLi9S5w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD04MDA-/https://media.zenfs.com/en/motleyfool.com/8e96de451397dbb49c7b58ff5aa7bb71","symbol":"BPMC","publisher":"Yahoo","summary":"The precision-treatment company saw stronger-than-expected sales in its first full quarter following the launch of Ayvakit.","url":"https://finance.yahoo.com/m/0ef9564f-c035-3b94-b68b-ab23bce08a05/why-blueprint-medicines-stock.html"},{"category":"company","date":1698334532,"headline":"Blueprint Medicines Corporation 2023 Q3 - Results - Earnings Call Presentation","id":123426769,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"BPMC","publisher":"SeekingAlpha","summary":"The following slide deck was published by Blueprint Medicines Corporation in conjunction with their 2023 Q3 earnings call.","url":"https://seekingalpha.com/article/4644012-blueprint-medicines-corporation-2023-q3-results-earnings-call-presentation"},{"category":"company","date":1698329461,"headline":"Blueprint Medicines Corporation (BPMC) Q3 2023 Earnings Call Transcript","id":123423710,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"BPMC","publisher":"SeekingAlpha","summary":"Blueprint Medicines Corporation (NASDAQ:NASDAQ:BPMC) Q3 2023 Earnings Conference Call October 26, 2023 8:00 AM ETCompany ParticipantsJenna Cohen - Vice...","url":"https://seekingalpha.com/article/4643940-blueprint-medicines-corporation-bpmc-q3-2023-earnings-call-transcript"},{"category":"company","date":1698327035,"headline":"Compared to Estimates, Blueprint Medicines (BPMC) Q3 Earnings: A Look at Key Metrics","id":123421649,"image":"https://media.zenfs.com/en/zacks.com/d0d4ab152198da2f423d92da8a7d22ee","symbol":"BPMC","publisher":"Yahoo","summary":"While the top- and bottom-line numbers for Blueprint Medicines (BPMC) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.","url":"https://finance.yahoo.com/news/compared-estimates-blueprint-medicines-bpmc-133035745.html"},{"category":"company","date":1698324727,"headline":"Blueprint Medicines Corp (BPMC) Reports Q3 2023 Earnings","id":123415824,"image":"","symbol":"BPMC","publisher":"Yahoo","summary":"Revenue Growth and Operational Efficiency Highlighted in Latest Financial Results","url":"https://finance.yahoo.com/news/blueprint-medicines-corp-bpmc-reports-125207949.html"},{"category":"company","date":1698323700,"headline":"12 Health Care Stocks Moving In Thursday's Intraday Session","id":123422445,"image":"","symbol":"BPMC","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3179549407"},{"category":"company","date":1698323580,"headline":"Blueprint Medicines Shares Surge as Ayvakit Sales Top Views","id":123428810,"image":"https://mw3.wsj.net/mw5/content/logos/mw_logo_social.png","symbol":"BPMC","publisher":"MarketWatch","summary":"By Colin Kellaher Blueprint Medicines shares jumped more than 25% on Thursday after the precision-therapy company posted better-than-expected quarterly sales...","url":"https://www.marketwatch.com/story/blueprint-medicines-shares-surge-as-ayvakit-sales-top-views-2f724aa1"},{"category":"company","date":1698323340,"headline":"Why Harley-Davidson Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session","id":123422446,"image":"","symbol":"BPMC","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3179537334"},{"category":"company","date":1698322517,"headline":"Blueprint Medicines (BPMC) Reports Q3 Loss, Tops Revenue Estimates","id":123421651,"image":"https://media.zenfs.com/en/zacks.com/3d7c5b2146ac04ffd51752e17ff2a619","symbol":"BPMC","publisher":"Yahoo","summary":"Blueprint Medicines (BPMC) delivered earnings and revenue surprises of 7.95% and 14.09%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?","url":"https://finance.yahoo.com/news/blueprint-medicines-bpmc-reports-q3-121517562.html"},{"category":"company","date":1698321420,"headline":"LIXT, LIPO and HRYU among mid-day movers","id":123422447,"image":"","symbol":"BPMC","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3179481540"},{"category":"company","date":1698318000,"headline":"Blueprint Medicines Reports Third Quarter 2023 Results","id":123421652,"image":"https://media.zenfs.com/en/prnewswire.com/c740bc0c838c53d3519efe12ecb79940","symbol":"BPMC","publisher":"Yahoo","summary":"Blueprint Medicines Corporation (NASDAQ: BPMC) today reported financial results and provided a business update for the third quarter ended September 30, 2023.","url":"https://finance.yahoo.com/news/blueprint-medicines-reports-third-quarter-110000647.html"},{"category":"company","date":1698317880,"headline":"What You Missed On Wall Street This Morning","id":123419171,"image":"","symbol":"BPMC","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3179383586"},{"category":"company","date":1698317820,"headline":"IBM, ServiceNow, Lennox, Morningstar And Other Big Stocks Moving Higher On Thursday","id":123419368,"image":"","symbol":"BPMC","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3179382256"},{"category":"company","date":1698315900,"headline":"Blueprint Medicines stock climbs after Q3 beats","id":123422450,"image":"","symbol":"BPMC","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3179329920"},{"category":"company","date":1698311100,"headline":"Align Technology, ImmunityBio among healthcare movers","id":123419370,"image":"","symbol":"BPMC","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3179203105"},{"category":"company","date":1698304080,"headline":"Blueprint Medicines: Q3 Earnings Snapshot","id":123422453,"image":"","symbol":"BPMC","publisher":"Associated Press, The","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=99pvrlvnlv"},{"category":"company","date":1698302280,"headline":"Blueprint Medicines reports Q3 EPS ($2.20), consensus ($2.37)","id":123422458,"image":"","symbol":"BPMC","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3178996859"},{"category":"company","date":1698300960,"headline":"Blueprint Medicines  GAAP EPS of -$2.20 beats by $0.18, revenue of $56.57M beats by $5.92M","id":123422460,"image":"","symbol":"BPMC","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3178972257"},{"category":"company","date":1698299160,"headline":"Blueprint Medicines: A Promising Investment with Robust Financial Performance and Innovative Pipeline – A Buy Recommendation by Marc Frahm","id":123462541,"image":"","symbol":"BPMC","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3180141504"},{"category":"company","date":1698291300,"headline":"What You Missed On Wall Street On Thursday","id":123432347,"image":"","symbol":"BPMC","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3179871259"},{"category":"company","date":1698243300,"headline":"Drug, Biotech Stocks' Q3 Earnings Due on Oct 26: BMY, MRK, BPMC","id":123390628,"image":"https://media.zenfs.com/en/zacks.com/8caea1d10b17de34fac5dfab9fa21224","symbol":"BPMC","publisher":"Yahoo","summary":"Let's look at three biotech/drug companies, BMY, MRK and BPMC, slated to release quarterly results on Oct 26.","url":"https://finance.yahoo.com/news/drug-biotech-stocks-q3-earnings-141500234.html"},{"category":"company","date":1698228000,"headline":"Notable earnings before Thursday's open","id":123390406,"image":"","symbol":"BPMC","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3177231480"},{"category":"company","date":1698224220,"headline":"Blueprint Medicines (BPMC) Initiated with a Buy at Berenberg Bank","id":123422461,"image":"","symbol":"BPMC","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3178384274"},{"category":"company","date":1698196740,"headline":"Blueprint Medicines Q3 2023 Earnings Preview","id":123400780,"image":"","symbol":"BPMC","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3177535561"}]}